ArticleJournal of health economics2011
The impact of comparative effectiveness research on health and health care spending.
Article in Journal of health economics, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed.
- The Impact of Incentives on Weight Control in Men: A Randomized Controlled Trial.American journal of men's healthTrial
- Opportunities to Increase Science of Diversity and Inclusion in Clinical Trials: Equity and a Lack of a Control.Journal of the American Heart Association · 2023Review
- The Modest Effects of Fact Boxes on Cancer Screening.Journal of risk and uncertainty · 2021Article
- The value of survival gains from therapeutic innovations for US patients with relapsed/refractory multiple myeloma.Therapeutic advances in hematology · 2021Article
- Impact of Health Care Reform on Technology and Innovation.Hand clinics · 2020Review
- Using the Bayesian credible subgroups method to identify populations benefiting from treatment: An application to the Look AHEAD trial.PloS one · 2020Article
- Racial and Socioeconomic Differences Manifest in Process Measure Adherence for Enhanced Recovery After Surgery Pathway.Diseases of the colon and rectum · 2017Article
- Impact of a Value-based Formulary on Medication Utilization, Health Services Utilization, and Expenditures.Medical care · 2017Article
- Welfare implications of learning through solicitation versus diversification in health care.Journal of health economics · 2015Article
- Establishing a composite endpoint for measuring the effectiveness of geriatric interventions based on older persons' and informal caregivers' preference weights: a vignette study.BMC geriatrics · 2014Article
- Heterogeneity in action: the role of passive personalization in comparative effectiveness research.Health economics · 2014Article
- Patient-centered or 'central' patient: Raising the veil of ignorance over randomization.Statistics in medicine · 2012Article
- Tying comparative effectiveness information to decision-making and the future of comparative effectiveness research designs: the case for antipsychotic drugs.Journal of comparative effectiveness research · 2012Article
- The pragmatist's guide to comparative effectiveness research.The journal of economic perspectives : a journal of the American Economic Association · 2011Article
- Perspectives on comparative effectiveness research: views from diverse constituencies.PharmacoEconomics · 2010Article
- ESTIMATING PERSON-CENTERED TREATMENT (PeT) EFFECTS USING INSTRUMENTAL VARIABLES: AN APPLICATION TO EVALUATING PROSTATE CANCER TREATMENTS.Journal of applied econometrics (Chichester, England)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Comparative effectiveness research (CER) is thought to identify what works and does not work in health care. We interpret CER as infusing evidence on product quality into markets, shifting the relative demand for products in CER studies. We analyze how shifts in demand affect health and health care spending and demonstrate that CER may raise or lower overall health when treatments have heterogeneous effects, but payers respond with product-specific coverage policies. Among patients with schizophrenia, we calibrate that subsidy policies based on the clinical trial CATIE may have reduced overall health by inducing some patients to switch away from schizophrenia treatments that were effective for them towards winners of the CER.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.